The Lawxy Times
European Commission conditions AkzoNobel‑Axalta merger on required divestiture
On 6 November 2026 the European Commission granted conditional clearance to the proposed merger of AkzoNobel and Axalta. The clearance is conditioned on the divestiture of AkzoNobel’s vehicle‑refinish coatings business in Europe. The decision affects the parties to the transaction and any competitor in the vehicle‑refinish coatings market. It clarifies the Commission’s willingness to impose structural remedies in horizontal concentration cases.
Full News Breakdown
The Commission opened a formal review after the parties notified the transaction under the EU merger control framework. Competition concerns centred on the combined position in the vehicle‑refinish coatings market, prompting the Commission to seek a remedy. It ultimately approved the merger subject to a divestiture condition.
Case Name: AkzoNobel – Axalta merger
Court: European Commission, Competition Directorate‑General
Panel: Not disclosed
Date: 6 November 2026
Citation: M.12269
EU Instruments / UK Legislation Cited: Council Regulation (EC) No 139/2004 (EU Merger Regulation)
Key Provisions: Article 9(3) MER
Primary Legal Issue: Whether the merger would significantly impede effective competition in the vehicle‑refinish coatings market
Applicant/Plaintiff Arguments: The parties argued that the combined entity would retain sufficient competition and that efficiencies would outweigh any overlap.
Respondent/Defendant Arguments: The Commission contended that the merged entity would achieve a dominant position in several national markets, reducing choice for automotive manufacturers.
Court's Reasoning: The Commission applied the “significant impediment” test, found that the overlap created a concentration exceeding the 30 % market‑share threshold, and concluded that only a full divestiture could restore competitive equilibrium.
Holding: Conditional clearance subject to divestiture of AkzoNobel’s vehicle‑refinish coatings business in Europe
Operative Order: The divested assets must be sold to an existing coatings operator or a firm operating in a related economic sector before the merger can be consummated.
Practical Outcome: The merger may proceed once the required divestiture is completed and the Commission is notified of the transaction.
How Does This Affect You?
Before the decision, parties to horizontal mergers in the coatings sector faced uncertainty about whether the Commission would require structural remedies or could rely on behavioural commitments. The Commission now expressly mandates a divestiture of the overlapping vehicle‑refinish segment as a pre‑condition for clearance. This makes the timing of any such merger dependent on identifying a qualified buyer and completing the sale, thereby reducing the risk of a later prohibition and sharpening the focus on structural solutions. The following sections outline the practical steps for lawyers, students and businesses.
For Lawyers & Advocates
Amend pending merger filings to include a detailed divestiture commitment that references Article 9(3) MER and outlines the timeline for asset transfer.
Revise the competition clearance checklist for clients in the coatings industry to incorporate a mandatory market‑share analysis for vehicle‑refinish products before any merger is announced.
Prepare a template “Divestiture Agreement” that satisfies the Commission’s requirement that the buyer be an existing coatings operator or a firm in a related sector, and file the accompanying notification under the EU Merger Regulation.
Use this decision as precedent when arguing for structural remedies in future horizontal cases, emphasizing the Commission’s willingness to condition clearance on full asset sales rather than behavioural undertakings.
Advise clients that the risk of a delayed closing is now largely tied to the identification of a qualified purchaser; advise early engagement with potential buyers to mitigate timing risk.
For Law Students
This case illustrates how the Commission applies the “significant impediment” test under the EU Merger Regulation to assess horizontal overlaps. The core doctrinal focus is the interpretation of Article 9(3) MER, which permits the Commission to impose structural remedies when competition is likely to be substantially reduced.
The decision is particularly relevant for the study of:
EU competition law – merger control doctrine
Structural remedies – divestiture analysis
Market definition and concentration thresholds
Procedural aspects of the EU Merger Regulation filing process
Comparative competition law – remedies in the United States and UK
Comparable cases include AstraZeneca‑Novartis (2022, European Commission) and Bayer‑Monsanto (2018, European Commission). Comparing them shows how the Commission’s approach to structural remedies has evolved from conditional approvals to outright divestiture requirements when market shares cross critical thresholds.
For Businesses
Boards of automotive‑coatings companies must now review any planned acquisition of a competitor to ensure that a qualified divestiture partner can be identified before signing definitive agreements.
Finance teams should adjust internal cash‑flow models to account for the potential proceeds and timing of a required asset sale, as the divestiture must be completed prior to merger completion.
Compliance officers need to update internal merger‑control monitoring systems to flag overlaps in the vehicle‑refinish segment and trigger early consultation with competition counsel.
Procurement departments should assess whether existing supplier contracts could be affected by a forced divestiture, ensuring continuity of supply post‑sale.
Key Takeaways
The Commission now states that, where a horizontal concentration exceeds the 30 % market‑share threshold in a specific product market, a full divestiture of the overlapping assets is a permissible and often required remedy under Article 9(3) MER.
Practitioners must embed a detailed divestiture commitment in merger notifications and prepare ancillary agreements well before the closing date.
The Commission can block a merger outright if the required divestiture is not identified, limiting its reliance on behavioural commitments in similar sectors.
Watch for the European Commission’s forthcoming guidelines on “acceptable buyers” for structural remedies, expected in early 2027, which will refine the criteria for qualifying purchasers.
In‑house counsel should audit all pending merger dossiers by 31 December 2026 to ensure that any vehicle‑refinish overlap is addressed with a concrete divestiture plan before the next filing deadline.
Source: AkzoNobel-Axalta merger wins conditional EU clearance
